These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6156069)

  • 1. Binding of chlormadinone acetate to cytosol from human benign prostatic hypertrophy.
    Kodama T; Wakisaka M; Shimazaki J
    Endocrinol Jpn; 1980 Feb; 27(1):53-7. PubMed ID: 6156069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy.
    Kodama T; Hasebe C; Shimazaki J
    Endocrinol Jpn; 1980 Apr; 27(2):229-37. PubMed ID: 6157523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiprostatic agents on 5alpha-dihydrotestosterone binding to rat hypophyseal and hypothalamic cytosol macromolecules.
    Yamanaka H; Matsuoka M; Yuasa H; Koya A; Imai K; Ebihara K; Nakai K; Shida K
    Endocrinol Jpn; 1979 Feb; 26(1):97-102. PubMed ID: 86441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.
    Ghanadian R; Smith CB; Williams G; Chisholm GD
    Br J Urol; 1977; 49(7):695-700. PubMed ID: 74269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of androphilic proteins in cytosols of human benign prostatic hypertrophy.
    Kodama T; Shimazaki J
    Endocrinol Jpn; 1979 Aug; 26(4):449-58. PubMed ID: 91507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a specific dihydrotestosterone-binding cytosol receptor in the human prostate.
    Geller J; Cantor T; Albert J
    J Clin Endocrinol Metab; 1975 Nov; 41(5):854-62. PubMed ID: 52654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrotestosterone-binding protein in cytosols of normal and hypertrophic human prostates, and influence of estrogens and anti-androgens on the binding.
    Shimazaki J; Kodama T; Wakisaka M; Katayama T
    Endocrinol Jpn; 1977 Feb; 24(1):9-14. PubMed ID: 67940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line.
    Térouanne B; Paris F; Servant N; Georget V; Sultan C
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):143-7. PubMed ID: 12573824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the androgen-binding proteins in human benign prostatic hypertrophy].
    Tomioka O
    Hinyokika Kiyo; 1983 Mar; 29(3):267-85. PubMed ID: 6203381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by various steroids on dihydrotestosterone binding to androphilic protein in human benign prostatic hypertrophy.
    Kodama T; Honda S; Shimazaki J
    Endocrinol Jpn; 1978 Oct; 25(5):453-60. PubMed ID: 84756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.
    Petrangeli E; Sciarra F; Di Silverio F; Toscano V; Lubrano C; Conti C; Concolino G
    J Steroid Biochem; 1988; 30(1-6):395-9. PubMed ID: 2455099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-binding proteins in human benign prostatic hypertrophy.
    Rosen V; Jung I; Baulieu EE; Robel P
    J Clin Endocrinol Metab; 1975 Oct; 41(4):761-70. PubMed ID: 51854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cyproterone acetate with rat prostatic androgen receptors.
    Traish AM; Muller RE; Wotiz HH
    Steroids; 1985; 45(3-4):247-62. PubMed ID: 2939604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
    Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
    de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of mechanisms of the action of androgens on prostate. 3. Anti-androgenic effect of gestagenic compounds and treatment of benign prostatic hypertrophy with chlormadinone acetate].
    Shida K; Shimazaki J; Urano E; Kurihara H; Takahashi H
    Nihon Hinyokika Gakkai Zasshi; 1972 Feb; 63(2):109-28. PubMed ID: 4113183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dihydrotestosterone-binding characteristics in human prostatic adenoma].
    Gerasimova TsI; Smirnov AN; Buniatian AF
    Probl Endokrinol (Mosk); 1982; 28(5):37-42. PubMed ID: 6183657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of androgen binding sites by exchange with methyltrienolone (R 1881).
    Bonne C; Raynaud JP
    Steroids; 1976 Apr; 27(4):497-507. PubMed ID: 58452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
    Kazama T; Mizuno I; Takamine T; Umeda K; Terada T; Ishikawa S; Fuse H; Katayama T
    Hinyokika Kiyo; 1990 Dec; 36(12):1423-7. PubMed ID: 1706136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.